Stock Events

Stock Events

NetraMark

€0.4020

16

+€0.01+1.26% 18:48 Today

Statistics

Day High

0.412

Day Low

0.376

52W High

0.975

52W Low

0.352

Volume

-

Avg. Volume

-

Mkt Cap

38.04M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Financials

-1,149.61%Profit Margin

Unprofitable

2020

2021

2022

2023

2024

2025

287,292.1Revenue

-3.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PF0.STU. It's not an investment recommendation.

YieldMax MSTR Option Income Strategy

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a major player in the pharmaceutical industry, directly competing with NetraMark in drug development and personalized medicine.

Novartis is involved in advanced pharmaceuticals and personalized healthcare solutions, overlapping with NetraMark's focus areas.

Merck operates in the pharmaceutical sector, focusing on innovative therapies that compete with NetraMark's offerings.

Eli Lilly is a leader in pharmaceuticals, particularly in areas that utilize AI for drug discovery, similar to NetraMark's approach.

GlaxoSmithKline focuses on research in pharmaceuticals, competing with NetraMark in the development of new drugs and health solutions.

AbbVie works in biopharmaceuticals, directly competing with NetraMark in therapeutic areas and personalized medicine.

Amgen specializes in biotechnological medicines, which aligns with NetraMark's focus on innovative healthcare solutions.

Bristol-Myers Squibb

Bristol-Myers Squibb is a major biopharma company, competing in the same space as NetraMark with a focus on serious diseases.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals focuses on genetic and biomarker-driven drug development, similar to NetraMark's AI-driven approach.

Vertex Pharmaceuticals

Vertex Pharmaceuticals is known for its scientific innovations in healthcare, competing with NetraMark in drug discovery and development.

About

Nurosene Health Inc. operates as a Canadian, technology-focused wellness company, primarily engaged in formulating its own distinctive range of nutraceutical products. Its offerings include Nuro Drive, designed to enhance physical stamina and mental acuity, and Nuro Restore, which aims to improve sleep quality while alleviating stress, pain, and inflammation. Beyond its product lines, Nurosene is also developing a mobile application for virtual care, intended to offer continuous assistance to individuals managing mental health challenges. The company was founded in 2019 and operates from its headquarters in Toronto, Canada.

Show more...

CEO

Country

Canada

ISIN

CA64119M1059

WKN

000A3D5X9

Listings

0 Comments

Share your thoughts

FAQ

What is NetraMark stock price today?▼

The current price of PF0.STU is €0.40 EUR — it has increased by +1.26% in the past 24 hours. Watch NetraMark stock price performance more closely on the chart.

What is NetraMark stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange NetraMark stocks are traded under the ticker PF0.STU.

Is NetraMark stock price growing?▼

PF0.STU stock has risen by +2.55% compared to the previous week, the month change is a -6.29% fall, over the last year NetraMark has showed a -59.8% decrease.

What is NetraMark market cap?▼

Today NetraMark has the market capitalization of 38.04M

What is NetraMark revenue for the last year?▼

NetraMark revenue for the last year amounts to 287,292.1 EUR.

What is NetraMark net income for the last year?▼

PF0.STU net income for the last year is -3.3M EUR.

In which sector is NetraMark located?▼

NetraMark operates in the Other sector.

When did NetraMark complete a stock split?▼

NetraMark has not had any recent stock splits.